We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Clinical Research Data Warehouse Built for Customized Treatment Research

By HospiMedica International staff writers
Posted on 25 Jun 2009
A clinical data research warehouse has been built to speed the development of new treatments for diseases such as diabetes, cystic fibrosis, and cancer. More...
IBM (Armonk, NY, USA) reported that it has teamed with University of North Carolina Health Care (UNCHC; Chapel Hill, USA) to accomplish this task. With the storage provided by the Carolina Data Warehouse for Health (CDW-H), medical researchers can analyze vast amounts of patient data uncovering trends in a matter of seconds. This avoids the time-consuming manual analysis of large quantities of patient records and treatment options.

"With the deployment of the Carolina Data Warehouse for Health, we have been able to increase the timeliness of the information available to our researchers, staff, and physicians,” said Donald Spencer, M.D., MBA, associate director of medical informatics, UNC Health Care. "Because the system can also support general queries that relate to the diagnosis and treatment of a wide array of patients, we are now able to make more intelligent decisions leading to improved patient care.”

Built on IBM software and hardware with global services expertise, the CDW-H focuses on diabetes disease management and performance measurement. Dr. Spencer estimates that the warehouse has narrowed the time frame for clinical research significantly. Queries that would previously take weeks now take seconds, he noted. The entire workflow of preparatory research, through regulatory approval, to obtaining a data set will drop from months to weeks.

Currently the project is focused on three major subject areas: in the first--cohort selection--primary users are researchers who need to determine cohort availability for studies, grants, and clinical trial recruitment using "de-identified” (i.e., all personal information removed) data. In the second--diabetes data mart--primary users are clinicians and analysts in the practice area. They utilize the data mart to gain access to information and statistics on diabetics, and prediabetics for disease management, performance reporting, and analysis. In the third—the inpatient data mart--is primarily used by the Quality Improvement Office and hospital analysts to support performance improvement efforts, core measures reporting, and hospital patient population studies/analysis.

"This new data warehouse will allow healthcare professionals to work more intelligently, speeding the development of treatments for disease,” said Dan Pelino, general manager, Global Healthcare and Life Sciences, IBM. "Sharing data on this scale heralds a new era of healthcare, where coordinated, patient-centered care and an adherence to evidence-based medicine can improve the quality of care delivered to people around the world.”

The data warehouse is built on the IBM Health Integration Framework and takes advantage of InfoSphere and WebSphere software, running on System z mainframe and System p computers. UNCHC has now moved the data warehouse into production with secure web portal providing access to anatomized cohort query selection, diabetes and inpatient data marts, business intelligence reports and analytics applications, and supporting clinical translation research.

Related Links:
IBM
University of North Carolina Health Care



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.